Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Stock Overview
Explore Harrow Health, Inc. 11.875% Senior Notes due 2027’s financial performance, market position, analyst ratings, and future outlook.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
Key Financials
Key Financials
Market Cap
1.3B
P/E Ratio
-101.32
EPS (TTM)
N/A
ROE
-0.34%
HROWM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Harrow Health, Inc. 11.875% Senior Notes due 2027's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of HROWM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $24.90 for the NASDAQ listing.
Key metrics behind Harrow Health, Inc. 11.875% Senior Notes due 2027's NASDAQ-traded stock include a P/E ratio of -101.32 and a market capitalization of 1.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HROWM on the NASDAQ.